EN 
ES 
On November 6th, the National Kidney Foundation and NephCure will partner to host an Externally Led Patient-Focused Drug Development (EL-PFDD) meeting focused on APOL1 kidney disease (AKD). This unique opportunity allows people living with and impacted by APOL1 kidney disease to share their experiences, challenges, and treatment priorities directly with the US Food and Drug Administration (FDA) and other key stakeholders. The meeting will take place in Hyattsville, Maryland.
In-person attendance is highly encouraged. Alternatively, you can join the livestreamed meeting.
